Accept Jesus as your personal Savior! Trump 2024!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When you think we will be hearing something?
NWBO gained footing and look for reverse and picked up HGEN and JWEL for near term reversal.
3+ before the September meeting. Looks good here.
One good news release and no telling how high the bounce here.
July 29th there were $2.5 million in buys at .38 but went under the radar. I think we gear up for a dollar run when they decide to turn it lose, and yes much more on a partnership.
HGEN fractional gain. Yes we are way undervalued, but My synopsis….I’m so browlbeat in all my investments at this point, I feel guilt and shame to get any kind of a green day reprieve be it ever so small. I do still have the advantage of understanding I‘m still significantly underwater and so that helps a little…lol
I assume serious partnership discussions are underway for CAR-T. The management and board have excellent contacts and respect in the industry. But we are now a clinical trial company, not a late-stage company. And that means we have to wait much longer than expected and - of course! - the plan for the realignment of the company should be presented to us in a comprehensible way sometime soon. I currently find all of the processes extremely strange.
A few more words about Activ 5 and Covid.
We ll hear something about the Korean trial in the fourth quarter, which could be helpful. And I m convinced anyway that we re going to see some decent data yet from ACTIV 5. For example, if you set a goal of achieving 100% on an exam but only manage 85%, that's a good number but not meaningful enough.
Lenzilumab neutralizes GM-CSF Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that drives the generation of myeloid cell subsets including neutrophils, monocytes, macrophages, and dendritic cells in response to stress, infections, and cancers. While too little GM-CSF prevents the appropriate production of innate immune cells and subsequent activation of adaptive anti-cancer immune responses, too much of GM-CSF can exhaust immune cells and promote cancer growth. Many preclinical studies, using GM-CSF deletion or depletion approaches, have demonstrated that GM-CSF has a wide range of biological functions, including the mediation of inflammation and pain, indicating that it can be a potential target in many inflammatory and autoimmune conditions. We know that CMML is an open trial and we have 3 out of 3 responses. Rating should start soon. And maybe this study will be revived? (By Gilead?)
More informative insider link on Dale. https://www.insidertrades.com/humanigen-inc-stock/dale-chappell/
Now that earnings is over, Dale will add a ton more shares down here to average down his May purchases. https://www.sec.gov/Archives/edgar/data/1178179/000101359422000446/xslF345X03/form4.xml
Continuing to ride this one!
Buy with both fists right now! Bottom is in and this soon spikes hard! Look for Dale to add back a bunch of shares soon! This is ripe!
activ 5 was not for statistical significance (tld) this is about a signal of efficacy , which then leads to a larger platform study. proof: website activ-5 bet b - awaiting results had the data from activ5 clearly supported live-air results, hgen probably could have submitted an amendment to eua. proof: hgen-presentations january, conferences it was clear from the beginning that hgen would not be able to carry out the further platform study on its own. they will therefore have been looking for a partner for some time + this partner might also resume the activities in uk + eu again. hgen will focus on car-t. proof: pr + hgen mails to investors
Anyway, hold on to your shares and add more if you can because the shorts will soon have to cover like mad!
HGEN: NIH corrected their website... Activ 5 - awaiting results! https://www.nih.gov/activ/nih-funded-activ/activ-associated-clinical-trials
“Mr. Gorbachev, tear down this wall",
Selling has dried up! Massive short squeeze is coming soon!
HGEN been thrashed and suppressed. It’s going to have a sizeable technical bounce near term.
Strong reversal coming! Sold all my NISN to grab this down here.
Send some of those bids over to APTO. Plenty of cash on hand and great potential in the pipeline. Management needs firing imho but that’s the drag…lol
Like this set up. Sellers are gone as volume drying up for days ahead of a big short squeeze! Great pattern! Earnings will be soon and that always spikes this sucker!
Historically, this is the area it previously pumped to $24 from. https://charts.stocktwits.com/production/original_469168412.png
Big time!
Nice ride!
Come over to NISN
This one about to go from dull to exciting in a hurry! Loaded!
Volume has dried up and sellers are gone. We are about to catch a serious upside wave soon!
Time to let it fly! NISN is good value based on its Price-To-Earnings Ratio (1x) compared to the peer average (72.4x) and compared to the US Software industry average (37.3x).NISN ($0.73) is trading below our estimate of fair value ($93.12). Excellent balance sheet, very undervalued with high growth potential. EPS $1.41
Something else. Congrats
Undiscovered still, but time to get on board. Recent 8 million buyback. What NISN predicted about its 2021 net profits was correct, they were about $30 million. For 2022, they expect $59.5 million net income and for 2023 they estimate about $100 million.
What NISN predicted about its 2021 net profits was correct, they were about $30 million. For 2022, they expect $59.5 million net income and for 2023 they estimate about $100 million. People need to find this. Dirt cheap.
BABA looking good here. Don’t sleep on little NISN while at it.
Sleeping giant! You and I both know they can turn this loose any moment so you kind of have to keep a close watch on it. It usually starts the day with a delayed reaction, but for all we know it could also spike to a buck in a blink. Just whenever they get ready to turn loose a little volume. Anyway, don’t blink and miss it! God bless and have a good day!
Sleeping giant! You and I both know they can turn this loose any moment so you kind of have to keep a close watch on it. It usually starts the day with a delayed reaction, but for all we know it could also spike to a buck in a blink. Just whenever they get ready to turn loose a little volume. Anyway, don’t blink and miss it! God bless and have a good day!
Low floater to keep an eye on ready to make some noise… NISN dd
When they let it go it will fly! Stay aboard!
Getting noticed. Could go parabolic any time! Today’s news is significant update to show their commitment. This is way undervalued!
Positives:
Munger is investing in Chinese stocks.
p/e 0.83
p/s .16
Market cap: ~16 million
Sales: 106 million
Net income: 20 million
p/tangible book value: 0.4
5 yr average sales growth: 20%
5 yr average eps growth 10%
Fair value using DCF and 3% growth is $3.68 with current price .81. Giving a 454% margin of safety.
47 million in cash.
59 million in net tangible assets (Impling 368% cigar butt return minimum).
143 million in assets and 52 million in total debt.
Lots of contracts with big names in a big industry in China.
Good opportunity to expand.